Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mora Telematika Indonesia Tbk. (MORA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Mora Telematika Indonesia Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Mora Telematika Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mora Telematika Indonesia Tbk. trades at Rp5,175 (market cap 254.4T, 166K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mora Telematika Indonesia Tbk. is far larger — about 2436.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

MORASCPI
Market Cap
254.4T104.4B
Volume
166K
Lot
1.66K
Turnover
863.82M
Average Price
5,203.75
Value
863.82M
Indicative Equilibrium Price
5,175
Indicative Equilibrium Volume
45

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MORA
View details
SCPI
View details

About Mora Telematika Indonesia Tbk.

PT Mora Telematika Indonesia Tbk (the Company) was established based on the Notarial Deed No. 30 dated August 8, 2000 of Daniel Parganda Marpaung, S.H., a public notary in Jakarta. The Company started its commercial operations in 2001. PT Candrakarya Multikreasi is the parent company. Ir. Galumbang Menak and Farida Bau are the ultimate shareholders of the Company and its subsidiaries (herein after referred to as the Group). The Group is incorporated in Indonesia and conduct its operations in Indonesia and Singapore.

Read more on MORA

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI